Ti/sub 5/Si/sub 3/
Aptamer-functionalized peptide H<sub>3</sub>CR<sub>5</sub>C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
... (H 3 R 5 ), as a reducible vector, cell penetrating peptide-modified aptamer (ST21) with specific binding to HCC cells to conjugate to peptide H 3 R 5 as the targeting probe, miRNA-195 ...
15
Reversal of multidrug resistance by magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
... NP-Fe 3 O 4 combined with DNR; 5-BrTet combined with DNR; 5-BrTet and MNP-Fe 3 O 4 combined with DNR, ...tumors, 5-BrTet and MNP-Fe 3 O 4 combined with DNR signifi cantly ...
6
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... Van/Fe 3 O 4 @SiO 2 @Ag microflower with enhanced antibacterial activity is experimentally and theoretically presented in this ...Van/Fe 3 O 4 @SiO 2 @Ag microflowers can rapidly and effectively kill both ...
18
Serotonin (5-HT<sub>3</sub>) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
... the 5-HT 3 ...of 5-HT 3 antagonists on defecatory disorders regardless of the duration from either initial surgery or closure of the ...that 5-HT 3 antagonists are effective for ...
6
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... Fe 3 O 4 nano magnetofluid (0.5, 1.0, 1.5, and 2.0 g/L Fe 3 O 4 ), and a simple magnetic field irradiation group (a negative control group plus magnetic field ...and 5% CO 2 with saturated humidity, ...
10
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... day 3 after ...day 3, and thereafter decreased ...Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...day 3 after dosing, indicating that the liver and spleen were the ...
6
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... All animals were kept in stress-free, hygienic, and animal- friendly conditions (relative humidity 60% ± 10%, room tem- perature 20 ° C ± 2 ° C, and 12-hour light/dark cycle). Food and water were available ad libitum. ...
15
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... suspension was placed in a 96-well microtiter plate in 200 µ L aliquots, and cultured in the presence or absence of T-cell mitogen (concanavalin A [ConA], Sigma, USA) (5 µ g/mL). Meanwhile the wells receiving ...
7
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... Abstract: Poor toxicity characterization is one obstacle to the clinical deployment of Gd 2 O 3 @ SiO 2 core-shell nanoparticles (Gd-NPs) for use as magnetic resonance (MR) imaging contrast agents. To date, there ...
11
Effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4 </sub>and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
... Fe 3 O 4 (MNPs-Fe 3 O 4 ) and 5-bromotetrandrine (BrTet) MDR cell line K562/A02 solitarily or ...MNPs-Fe 3 O 4 and BrTet with effective concentrations significantly increased cytotoxicity ...
8
Sub-10 nm Cu<sub>5</sub>FeS<sub>4</sub> cube for magnetic resonance imaging-guided photothermal therapy of cancer
... Cu 5 FeS 4 crys- tal (Joint Committee on Powder Diffraction Standards card ...Cu 5 FeS 4 crystal. The morphology and size of the obtained Cu 5 FeS 4 crystal were observed by the ...Cu 5 FeS 4 ...
10
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... with 5 mg EDC and 5 mg NHS for 30 minutes at room ...with 5 mg PLGA, then intermittently sonicated for 30 minutes at room ...with 5 mg EDC, 5 mg NHS, and 500 µ L DOX (2 ...for 3 ...
9
Decreased bacteria activity on Si<sub>3</sub>N<sub>4</sub> surfaces compared with PEEK or titanium
... tryptone, 5 g yeast extract, and 5 g NaCl per liter double-distilled water with the pH adjusted to ...with 3 mL of fresh LB supplemented with 10% ...
12
Magnetic nanoparticle of Fe<sub>3</sub>O<sub>4</sub> and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells
... Human leukemia cell line K562 and its adriamycin-selected Pgp-overexpressing subline K562/A02 were obtained from the Institute of Hematology, Chinese Academy of Medical Sciences (Tianjin, China). Both cells were cultured ...
8
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... Fe 3 O 4 -magnetic nanoparticles (MNPs-Fe 3 O 4 ) on the expression of KCNQ 1 in cardiac muscle of mice at rest and at different times following a single bout of swimming ...MNPs-Fe 3 O 4 separately, ...
8
The durability of Mn–Mo–Sn–W–Sb–O/Ir<sub>1–x–y</sub>Sn<sub>x</sub>Sb<sub>y</sub>O<sub>2+0.5y</sub> /Ti oxygen evolution anode for hydrogen production from seawater electrolysis
... 1000 A.m −2 . Numbers of cracks and pores on the surface of anode are decreased to form a smooth surface after electrolysis for about 1545 h. This revealed that the filling of cracks and pores by the beneficial ions ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Fe 3 O 4 -MNPs/DNR were injected intraperitoneally at a dose of 100 mg/kg (according to the therapeutic dose of DNR), whereas the control group was administered isodose DNR calculated by the effective drug-loading ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... OH 3 HCl and HAuCl 4 ) were performed during the reaction, and the stirring continued for at least 30 minutes after each ...Fe 3 O 4 @Au composite ...
15
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... Fe 3 O 4 -PLGA NP group and the Fe 3 O 4 -PLGA- cRGD NP ...FeCl 3 injury to the abdominal aorta and at 0 min, 10 min, 20 min, 30 min, 1 h, 2 h, and 3 h after injection of the ...Fe 3 O ...
14
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... MNPs-Fe 3 O 4 , or the copolymer of ART with MNPs- Fe 3 O 4 in the presence or absence of 40 µ M Z-VAD-FMK for 48 ...L, 5 mg/mL) was added to each well and incubated for 4 ...
8